Notably, our previous research highlighted how individuals with T2D initiate GLP-1 RA treatment at lower A1c and BMI levels in more recent years (Cartwright et al., 2024), reflecting a trend toward broader and more accessible use of these drugs
Yes, THC in cannabis commonly increases appetite ("the munchies"), which may counteract tirzepatide's appetite-suppressing effects and lead to increased caloric intake, potentially compromising weight management goals
We don't have the physician-founded clinical oversight of BistroMD
Recent data show discontinuation rates reaching significant levels particularly among people using them primarily for weight loss rather than diabetes control
Active-duty service members struggling with obesity are 33% to 47% more likely to suffer musculoskeletal problems, contributing to injuries, impaired readiness and possible medical separation, according to a Defense Health Agency-funded study published in August
Some came close to making the cut with research-backed strains and ease of swallowing, while others fizzled out due to high price tags or lack of quality assurance